---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-051355"
form_type: "8-K"
ticker: "ORMP"
cik: "0001176309"
company_name: "ORAMED PHARMACEUTICALS INC."
filed_at: "2024-06-10T23:59:59+00:00"
generated_at: "2026-06-01T05:14:58.502764+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Oramed Pharmaceuticals appoints Avraham Gabay as CFO effective June 18, 2024

## Summary
- Avraham Gabay appointed CFO, Treasurer, and Secretary, effective June 18, 2024.
- Gabay previously served as interim CFO of BiomX Inc. (NYSE American: PHGE) since 2023.
- He served as CFO of Oramed from 2019-2021 and as CFO of its 63% subsidiary Oravax Inc. from 2021-2023.
- Compensation: gross monthly salary NIS 68,000, company car, eligibility for bonuses and equity at board discretion.
- Gabay holds law and accounting degree from Tel-Aviv University, is a CPA in Israel and member of Israeli Bar.

## SEC filing metadata
- accession: 0001213900-24-051355
- form_type: 8-K
- ticker: ORMP
- cik: 0001176309
- company_name: ORAMED PHARMACEUTICALS INC.
- filed_at: 2024-06-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1176309/000121390024051355/0001213900-24-051355-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1176309/000121390024051355/ea0207486-8k_oramed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-051355
- JSON: https://secwatch.observer/filing/0001213900-24-051355.json
- Plain text: https://secwatch.observer/filing/0001213900-24-051355.txt

## Key facts
- Executive change
  Avraham Gabay was appointed as Chief Financial Officer, Treasurer and Secretary at ORAMED PHARMACEUTICALS INC..
  - Action: appointed
  - Role: Chief Financial Officer, Treasurer and Secretary
  source text: On June 6, 2024, Oramed Pharmaceuticals Inc. (the “Company”) appointed Mr. Avraham Gabay to serve as the Chief Financial Officer, Treasurer and Secretary of the Company, effective as of June 18, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1176309/000121390024051355/0001213900-24-051355-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.